Eris Lifesciences IPO vs S Chand and Company IPO

Comparision between Eris Lifesciences IPO and S Chand and Company IPO.

IPO Details

Eris Lifesciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while S Chand and Company IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Eris Lifesciences IPO	S Chand and Company IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Axis Capital Limited Citigroup Global Markets India Private Limited Credit Suisse Securities (India) Private Limited	Axis Bank Limited Credit Suisse Securities (India) Private Limited Jm Financial Limited
Registrar	Link Intime India Private Ltd	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Eris Lifesciences IPO is up to ₹1,741.16 Cr whereas the issue size of the S Chand and Company IPO is up to ₹728.56 Cr. The final issue price of Eris Lifesciences IPO is ₹603.00 per share and of S Chand and Company IPO is ₹670.00 per share.

	Eris Lifesciences IPO	S Chand and Company IPO
Face Value	₹1 per share	₹5 per share
Issue Price (Lower)	₹600.00 per share	₹660.00 per share
Issue Price (Upper)	₹603.00 per share	₹670.00 per share
Issue Price (Final)	₹603.00 per share	₹670.00 per share
Discount (Retail)
Discount (Employee)	₹60.00 per share
Market Lot Size	24 shares	22 shares
Fresh Issue Size		48,50,746 shares
Fresh Issue Size (Amount)		up to ₹325.00 Cr
OFS Issue Size	2,88,75,000 shares	60,23,236 shares
OFS Issue Size (Amount)		up to ₹403.56 Cr
Issue Size Total	2,88,75,000 shares	1,08,73,982 shares
Issue Size Total (Amount)	up to ₹1,741.16 Cr	up to ₹728.56 Cr

IPO Timetable

Eris Lifesciences IPO opens on Jun 16, 2017, while S Chand and Company IPO opens on Apr 26, 2017. The closing date of Eris Lifesciences IPO and S Chand and Company IPO is Jun 20, 2017, and Apr 28, 2017, respectively.

	Eris Lifesciences IPO	S Chand and Company IPO
Anchor Bid Date
Issue Open	Jun 16, 2017	Apr 26, 2017
Issue Close	Jun 20, 2017	Apr 28, 2017
Basis Of Allotment (Tentative)	Jun 23, 2017	May 04, 2017
Initiation of Refunds (Tentative)	Jun 27, 2017	May 05, 2017
Credit of Share (Tentative)	Jun 28, 2017	May 08, 2017
Listing date (Tentative)	Jun 29, 2017	May 09, 2017
Anchor Lockin End date 1	Jul 23, 2017	Jun 03, 2017
Anchor Lockin End date 2	Sep 21, 2017	Aug 02, 2017

Financials

Eris Lifesciences IPO P/E ratio is , as compared to S Chand and Company IPO P/E ratio of .

Eris Lifesciences IPO

S Chand and Company IPO

Financial

Summary of financial Information (Consolidated)
Particulars	For the year/period ended (in Rs. Million)
	31-Mar-16	31-Mar-15	31-Mar-14	31-Mar-13	31-Mar-12
Total Assets	3,973.59	3,572.85	2,705.99	1,718.05	1,019.67
Total Revenue	5,970.21	5,455.58	5,088.22	3,930.64	2,739.40
Profit After Tax	1,348.58	892.59	709.12	584.40	370.63

Summary of financial Information
Particulars	For the year/period ended (in Rs. Million)
	31-Dec-16	31-Mar-16	31-Mar-15	31-Mar-14	31-Mar-13	31-Mar-12
Total Assets	7,431.94	6,854.89	5,315.98	4,242.82	3,988.05	2,076.88
Total Revenue	922.12	2,822.53	2,357.88	2,300.32	1,921.72	1,713.21
Profit After Tax (PAT)	(300.39)	164.80	76.85	108.62	71.65	88.53

Promoter Shareholding (Pre-Issue)

Promoter Shareholding (Post-Issue)

P/E Ratio

Market Cap

ROE

ROCE

Debt/Equity

EPS

RoNW

Shares Offered

In the Eris Lifesciences IPO retail investors (RII) are offered 28,72,500 shares while in S Chand and Company IPO retail investors are offered 28,72,500 shares. Qualified institutional buyers (QIB) are offered 86,17,500 shares in Eris Lifesciences IPO and in S Chand and Company IPO.

	Eris Lifesciences IPO	S Chand and Company IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB	86,17,500 shares
NII	43,08,750 shares
RII	28,72,500 shares
Employee	1,50,000 shares
Others
Total	1,59,48,750 shares

Bids Received (Subscription)

Eris Lifesciences IPO subscribed 3.29x in total, whereas S Chand and Company IPO subscribed 59.49x.

	Eris Lifesciences IPO	S Chand and Company IPO
QIB (times)	4.68x	44.27x
NII (times)	0.45x	204.65x
Big NII (times)
Small NII (times)
RII (times)	3.51x	6.07x
Employee (times)	0.86x
Other (times)
Total (times)	3.29x	59.49x

Compare with others

Eris Lifesciences IPO	S Chand and Company IPO
SiS IPO	Eris Lifesciences IPO
Cochin Shipyard IPO	Tejas Networks IPO
Salasar Techno IPO	IndiGrid InvIT Fund
Au Financiers IPO	PSP Projects IPO
GTPL Hathway IPO	IRB InvIT Fund IPO
Tejas Networks IPO	HUDCO IPO
IndiGrid InvIT Fund	Shankara Buildpro IPO
PSP Projects IPO	CL Educate IPO
IRB InvIT Fund IPO	Radio City IPO
S Chand and Company IPO	CDSL IPO

Comments

Add a public comment...